Back to Market Feed

Product Information

BESIVANCE 0.6% SUSP is a brand product labeled by Bausch & Lomb Incorporated, priced at $44.1245 per ML under NDC 24208044605. Its NADAC has been published 665 times since Nov 28, 2013.

FDA first approved this application on May 28, 2009.

BESIVANCE 0.6% SUSP

Besifloxacin
$44.1245per ML

Strength

6 mg/mL

NDC

24208044605

Classification

Brand

Dosage Form

SUSPENSION

Route

OPHTHALMIC

Effective Date

8/19/2026

Active Ingredients

BESIFLOXACIN

Approval Type

New Drug (NDA)

FDA Application

NDA022308

FDA Approved

5/28/2009

On Market Since

5/28/2009

Pharmacological Classes

Quinolone Antimicrobial
Quinolones

Price Statistics

The NADAC for BESIVANCE 0.6% SUSP has been published 665 times since Nov 28, 2013, and over the history we have for it it has risen 111.9%. The table below summarizes its recorded NADAC range and movement.

Current price$44.1245 per ML
All-time high$44.2266 (Oct 15, 2025)
All-time low$20.8191 (Nov 28, 2013)
52-week high$44.2266
52-week low$44.0891
Median price$34.4471
Average price$34.1688
Largest weekly change+10.0% (Jan 14, 2015)
Weeks tracked665
Tracking sinceNov 28, 2013

Price History

1W

+0.0%

1M

+0.0%

3M

+0.1%

6M

+0.0%

1Y

-0.2%

3Y

+7.4%

5Y

+20.8%

All

+111.9%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Besifloxacin market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

OCUFLOX 0.3% EYE DROPS
Brand
11980077905•Allergan, Inc.
$22.6264
per ML
VIGAMOX 0.5% EYE DROPS
Brand
82667070003•Harrow Eye, LLC
$31.8080
per ML
CIPRO HC OTIC SUSPENSION
Brand
66758008770•Sandoz Inc.
$34.8676
per ML
ZYMAXID 0.5% EYE DROPS
Brand
00023361525•Allergan, Inc.
$67.3765
per ML
BAXDELA 450 MG TABLET
Brand
70842010101•Melinta Therapeutics, LLC
$72.3117
per EA
BAXDELA 450 MG TABLET
Brand
70842010102•Melinta Therapeutics, LLC
$72.3117
per EA
CILOXAN 0.3% OINTMENT
Brand
66758007138•Sandoz Inc.
$74.3262
per GM

Frequently asked questions

What is the NADAC price of BESIVANCE 0.6% SUSP?

The current National Average Drug Acquisition Cost (NADAC) for BESIVANCE 0.6% SUSP, manufactured by Bausch & Lomb Incorporated, is $44.1245 per ML (NDC 24208044605), effective Aug 19, 2026.

How has the price of BESIVANCE 0.6% SUSP changed over time?

Over the history we have for it, the NADAC for BESIVANCE 0.6% SUSP has risen 111.9%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for BESIVANCE 0.6% SUSP?

Since Nov 28, 2013, the NADAC for BESIVANCE 0.6% SUSP has ranged from a low of $20.8191 (Nov 28, 2013) to a high of $44.2266 (Oct 15, 2025), with a median of $34.4471 per ML.

Are there cheaper alternatives to BESIVANCE 0.6% SUSP?

No other NADAC-published product currently shares the active ingredient and strength of BESIVANCE 0.6% SUSP in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures BESIVANCE 0.6% SUSP?

BESIVANCE 0.6% SUSP (NDC 24208044605) is labeled by Bausch & Lomb Incorporated, and CMS classifies it as a brand product.